Skip to content

Soft Robot for Rehabilitation of Hand Function After Stroke

Design and Development of a Soft Robotic Glove for Enhanced Task-Oriented Training in Stroke Rehabilitation: Incorporating Dual-Chamber Actuators and Flexible Magnetoelastic Force Sensors

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07329075
Enrollment
60
Registered
2026-01-09
Start date
2026-01-31
Completion date
2028-12-31
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

upper limb, stroke rehabilitation, soft robotics

Brief summary

The goal of this clinical trial is to investigate the feasibility of using the Soft Forearm Robot system for wrist and forearm recovery of hemiplegic subjects suffered from stroke. Participant will attend 20 training sessions and 3 assessment sessions. This system will leverage electromyography (EMG) signals for intention detection and regulating the movement and the contact for different tasks and objects, ensuring adaptive and precise control for rehabilitation tasks. A systematic clinical study involving sixty stroke patients divided into three groups will evaluate the effectiveness of our innovative design compared to conventional rehabilitation methods. By conducting a randomized controlled trial (RCT), we aim to provide robust evidence on the benefits of our advanced robotic glove design in stroke rehabilitation. We hope our work will significantly advance the field of rehabilitation robotics by improving therapeutic practices, enhancing recovery outcomes, and elevating the quality of life for those facing hand mobility challenges. By integrating new soft robotic hand design with practical application, we aim to create an effective rehabilitation solution for everyone who needs it.

Interventions

DEVICEnew soft robotic glove

a soft robotic glove, with dual-chamber actuators

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* chronic stage (6 months post-onset); * adequate cognition to follow study instructions; * being able to sit for 30 minutes; * having detectable residual EMG signals from the affected side's flexor digitorum (FD) and extensor digitorum (ED) muscles, as well as the abductor pollicis brevis (APB) and flexor pollicis longus (FPL); and * Modified Ashworth Scale (MAS) score indicating levels of finger spasticity of 0, 1, 1+, 2, and 3 (i.e., 0 = no muscle tone to 3 = increase in tone, difficult in passive movement).

Exclusion criteria

* severe dysphasia, * conditions that could hinder study compliance, and * certain medical or psychological disorders, such as alcoholism and substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)3-month after interventionIt is used to evaluate and measure upper-limb recovery in post-stroke hemiplegic patients, and items are scored on a 3-point ordinal scale

Secondary

MeasureTime frameDescription
Modified Ashworth Scale (MAS)3-month after interventionIt measures the spasticity level of wrist, elbow and finger joint.
Box and Block Test (BBT)3-month after intervention
Action Research Arm Test (ARAT)3-month after interventionThe ARAT is a 19-item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement) to assess upper limb functioning
active range of motion (AROM) of fingers3-month after interventionrange of motion is a measurement to identify how far the person's joints range can move in flexion/extension
5Q-5D-5L questionnaire3-month after interventionIt is a quality of life questionnaire
Maximum Grip Strength (GRS)3-month after intervention

Countries

Hong Kong

Contacts

Primary ContactRaymond Tong, PhD
kytong@cuhk.edu.hk39438454

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026